Similar articles

• Pandemic influenza vaccination coverage in children with type 1 diabetes: analysis from seven Italian centers.

  Rabbone I, Scaramuzza AE, Iafusco D, Bonfanti R, Lombardo F, Cherubini V, Toni S, Cerutti F, Zuccotti GV. Rabbone I, et al. Hum Vaccin. 2011 Dec;7(12):1291-2. doi: 10.4161/hv.7.12.18335. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22108031
• Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus.

  Zuccotti GV, Pariani E, Scaramuzza A, Santoro L, Giani E, Macedoni M, Gazzarri A, Anselmi G, Amendola A, Zanetti A. Zuccotti GV, et al. Diabet Med. 2011 Dec;28(12):1530-6. doi: 10.1111/j.1464-5491.2011.03449.x. Diabet Med. 2011. PMID: 21916971 Clinical Trial.
• Influenza vaccines: the good, the bad, and the eggs.

  Schultz-Cherry S, Jones JC. Schultz-Cherry S, et al. Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Adv Virus Res. 2010. PMID: 20951870 Review.
• Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospital.

  Tanguy M, Boyeau C, Pean S, Marijon E, Delhumeau A, Fanello S. Tanguy M, et al. Vaccine. 2011 Jun 6;29(25):4190-4. doi: 10.1016/j.vaccine.2011.03.107. Epub 2011 Apr 15. Vaccine. 2011. PMID: 21497636
• [Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction].

  Zhang WW, Li L, Zhu FC. Zhang WW, et al. Zhongguo Yi Miao He Mian Yi. 2010 Jun;16(3):275-8. Zhongguo Yi Miao He Mian Yi. 2010. PMID: 20726275 Review. Chinese.